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Breast conservation surgery is available to the vast majority of women with breast cancer. The combination of neoadjuvant
therapies and oncoplastic surgical techniques allows even large tumours to be managed with a breast-conserving approach.
The relationship between breast size and the volume of tissue to be excised determines the need for volume displacement or
replacement. Such an approach can also be used in the management of carefully selected cases of multifocal or multicentric breast
cancer. The role of novel techniques, such as endoscopic breast surgery and radiofrequency ablation, is yet to be precisely deﬁned.
1.Introduction
The replacement of obligatory mastectomy, be it radical
or modiﬁed radical, by simple mastectomy or wide local
excision and adjuvant radiotherapy, reﬂected a paradigm
shift in the understanding of breast cancer pathology and
biology [1]. The combination of multimodal treatments,
both locoregional, in the form of conservation surgery
and radiotherapy, and systemic endocrine treatment and
chemotherapy, has resulted in reduced postsurgical morbid-
ity without compromising oncological outcomes [2]. The
concept of downstaging tumours by means of neo-adjuvant
chemotherapy or endocrine therapy is increasingly being
applied to improve the chance of successful conservation
surgery in the same way as it can render operable the inoper-
able [3, 4]. The adoption of oncoplastic surgical techniques
allows larger tumours to be excised safely without com-
promising cosmetic outcomes. Currently, the only absolute
contraindications to breast conservation relate to tumours
with chest wall involvement, signiﬁcant skin involvement,
and patients with either extensive malignant microcalciﬁ-
cations or inﬂammatory carcinoma [5, 6]. Multifocal and
multicentric tumours remain relative contraindications to
attempts at breast conserving surgery. Such patients need
careful counselling regarding the possible need for further
surgery if excision is incomplete, and the increased risk of
locoregionalrecurrence.Meticulouspreoperativeplanningis
essential if conservation is to be successful in this context
[7]. The role of salvage breast conservation surgery in the
managementoflocalrecurrence,orametachronousprimary
cancer, is controversial, and should be considered with
caution.
While some studies in the United States have suggested
that the increasing incidence of breast cancer may have
begun to level oﬀ [8], data from European countries does
not reﬂect this change [9, 10]. Survival from breast cancer
has certainly improved [11, 12], and it follows, therefore,
that there are more patients alive now, having survived
breast cancer, than at any other time. Aesthetic concerns
and expectations are understandably higher on patients’
agenda than previously and remain a source of psychological
morbidity after mastectomy or if the results from breast
conservation surgery are poor [12, 13]. Thus the importance
of the oncoplastic approach, deﬁned as the application of
plastic surgery techniques of partial breast reconstruction
at the time of breast cancer surgery, to optimising the
oncological and cosmetic outcomes of breast conservation,
has never been more keenly felt [14–16].
2.OptimisationofOncologicalFactors
Tumours may be successfully downstaged with neoadju-
vant chemotherapy and/or endocrine therapy, allowing the
majority of patients to undergo breast conservation surgery
[4, 17]. In this context, the decision to proceed with breast
conserving surgery is guided by the clinical and radiological2 International Journal of Breast Cancer
response to neoadjuvant therapy. Magnetic resonance imag-
ing is superior to mammography or ultrasound in evaluating
the response to neoadjuvant therapy and should be used
in preference [18–20]. Whereas regimens of neoadjuvant
chemotherapy usually last approximately six months, the
duration of endocrine therapy in the neoadjuvant context
is more varied. Although only used for three months in the
IMPACT trial [21], reductions in tumour size were suﬃcient
to allow breast conservation treatment in a large proportion.
Neoadjuvant endocrine treatment is sometimes associated
with a more gradual reduction in tumour size and can
safelybecontinuedforlongerdurationspriortoundertaking
curative breast conservation surgery [22].
Small lesions, which are impalpable or diﬃcult to
feel, should be localised stereotactically or by ultrasound.
A number of techniques are available, utilising hookwire
localisation, radioactive beads, or injection of radioisotope
colloid, the latter being particularly attractive in cases where
breast-conserving surgery is performed in conjunction with
sentinel lymph node biopsy [23, 24].
The use of intraoperative specimen X-ray helps conﬁrm
complete excision of the radiological abnormality [25]. This
has been shown to help reduce the need for further surgery
because of margin positivity, as a further cavity shave may be
taken intraoperatively if the specimen X-ray gives cause for
concern [26].
Optimal oncological treatment demands complete exci-
sion of malignant tissues with a negative resection margin.
What constitutes a negative margin is not well deﬁned.
In early studies, only margins of >1cm were considered
negative [27, 28]. A recent meta-analysis showed equivalent
rates of local recurrence with margins as close as 1-2mm
[29, 30], but closer margins have been associated with rates
of local recurrence similar to those seen in cases with positive
margins [31, 32].
Theuseofintraoperativefrozensectionforassessmentof
margins, where available, is helpful in reducing the number
of second procedures required to achieve clear margins
[33, 34]. A further cavity shave can be taken from any
margin found to be positive on intraoperative frozen section.
Intraoperative touch imprint cytology can also be used as
a means of margin assessment but, as with frozen section,
requirestheavailabilityofanexpertcytopathologisttoreport
slides intraoperatively [35].
The role of routine cavity biopsies is controversial [36].
Hewes et al. (2009) found poor correlation between the
status of the resection margin and cavity biopsies. In their
series, the status of cavity biopsies was a better predictor
of both breast-cancer-speciﬁc and overall survival. The two
key beneﬁts of this approach are the reduced need for
second operations if the specimen margin is positive and
the cavity biopsy negative and the diagnosis of otherwise
occult multifocal disease, often necessitating mastectomy
[37]. Conversely, it can be argued that the practice is both
unnecessary, given that discontinuous small foci of disease
are adequately treated by radiotherapy [28]a n du n d e s i r a b l e ,
as it inevitably results in the excision of more tissue than
strictly necessary, having a potentially adverse eﬀect on
cosmetic outcomes.
Rates of local recurrence after breast-conserving surgery
are signiﬁcantly reduced by the use of adjuvant radiotherapy,
givingratesofoverallsurvivalsimilartothosefollowingmas-
tectomy [38], and therefore should be viewed as a standard
of care, unless distant metastases are discovered soon after
surgery [39, 40]. Postoperative external beam whole-breast
radiotherapy remains the most commonly used technique,
although partial breast radiotherapy is possible, and may be
performed intraoperatively or postoperatively, via external
beam, brachytherapy, or photon emission [41–44]. There is
evidence that partial breast radiotherapy may be superior
in terms of cosmetic outcome [45]. This is often cited as a
major advantage over whole breast radiotherapy, which is
associated with a number of unfavourable cosmetic sequelae,
such as breast lymphoedema, ﬁbrosis, and shrinkage of
the breast tissue, often leading to accentuation of small
parenchymal defects and distortion of the nipple. However,
although short-term rates of local recurrence after partial
breast irradiation seem similar, long-term data (i.e., over
10 years) showing equivalence with traditional whole-breast
external beam radiotherapy are not yet available. The impor-
tance of reducing rates of 5-year locoregional recurrence is
emphasised by its relationship with 15-year mortality. The
20% reduction in 5-year locoregional recurrence associated
with the addition of radiotherapy to breast conservation
surgery corresponds to a 5% reduction in mortality at 15
years [46].
3.OptimisationoftheCosmeticOutcomeafter
BreastConservationSurgery
The cosmetic appearance of the breast after breast conser-
vation surgery depends, ﬁrstly, on the relative proportion
of breast volume excised in order to satisfy oncological
requirements and, secondly, on the location of the tumour
within the breast.
The cosmetic defect caused by excision of medial
tumours, especially in the upper inner quadrant, is more
pronounced than for tumours in the outer half of the breast.
Estimationoftheproportionofbreastvolumetobeexcisedis
thereforeanimportant consideration whenplanning surgery
[47]. Successful oncological and aesthetic outcome depends
on adequate preoperative planning. Mammography and
ultrasound alone may underestimate the extent of disease
and fail to demonstrate multifocality. Magnetic resonance
imaging is being used increasingly in this context, as it
has been shown to give a more accurate estimate of the
true distribution of malignancy, particularly for lobular
carcinomas [48, 49].
4.SurgicalPrinciples
Overview.
(i) General principles
(a) choice of incision,
(b) avoidance of nipple deviation.
(ii) Techniques for excision of <10% of breast volume.International Journal of Breast Cancer 3
(a) (b)
Figure 1: (a) This patient had previously undergone a central wide local excision and nipple reconstruction at the age of 47. Although
the contour of the right breast is similar to that of the left, there is a relative lack of projection and the breast has a blunted appearance. (b)
Autologousfattransfer,intheformoflipomodelling,successfullyﬁllsthedefectfromprevioussurgery.Thepatientalsoreceivedasubdermal
silicone areola prosthesis to improve projection of the reconstructed nipple.
(iii) Techniques for excision of 10–20% breast volume:
(a) volume displacement,
(b) central tumours,
(c) peripheral tumours.
(iv) Techniques for excision of >20% of breast volume:
(a) tissue transfer.
Incisions should follow Langer’s lines, semicircular, concen-
tric to the edge of the areola, or Kraissl’s lines, parallel to the
horizontal skin creases. Radial incisions can be useful, but
care must be taken to ensure that the nipple-areola complex
is not likely to be displaced as the scar contracts during the
process of wound healing and radiotherapy. A circumareolar
incision can give good access to most lesions except those at
the extreme periphery of the breast.
The skin overlying the cancer only needs to be excised if
there are concerns regarding skin involvement, for example,
ifthereisin-drawing oftheskinorﬁxeddimpling. Following
wide excisions, the resultant scarring and radiotherapy
changes tend to cause nipple deviation towards the scar. This
can be avoided by undermining the skin and disconnecting
the ducts behind the nipple-areola complex. If needed,
the remaining glandular tissue can also be undermined
to allow rotation and approximation of tissue into the
defect. If signiﬁcant NAC deviation is anticipated, then de-
epithelialisation of a crescent of skin from the areolar edge
that is opposite to the scar and resiting the nipple to adjust
for anticipated deviation often is helpful.
In general, excision of up to 10% of breast volume as
a simple wide local excision gives an acceptable cosmetic
result [47]. The resultant ﬁlling defect can be resolved to
some degree by generously undermining the surrounding
glandular tissue to allow it to ﬁll the wide excision cavity. For
those cases with defects despite breast remodelling the use of
autologous fat transfer (Figures 1(a) and 1(b)) is emerging as
Table 1
Mammoplasty techniques for resection of 10–20% of breast
volume:
Glandular remodelling
Inferior pedicle
Superior pedicle
Vertical scar
Round block
Grisotti ﬂaps
an attractive option [50]. However, dystrophic calciﬁcation
following fat necrosis may result in increased recall after
screening mammography for biopsy [51].
For cancers occupying up to 20% of breast volume,
some degree of volume displacement may be required
to ﬁll the defect [52]. This is achieved by mobilisation
and transposition of neighbouring glandular tissue with or
without overlying skin (see Table 1). Suitable patients with
adequate breast volume may wish to undergo therapeutic
mammoplasty [53]. Surgery to the contralateral breast may
be requested to improve symmetry and may take the form of
a reduction mammoplasty or mastopexy.
For cancers occupying 20–40% of the breast, volume
displacement alone may not be suﬃcient and thus volume
replacement by autologous tissue transfer may become
necessary.
5.OptimisingCosmesis: CentralTumours
Occupying 10–20% of Breast Volume
Subareolar tumours have previously been viewed as an
indication for mastectomy but may be safely approached by
central excision with resection of the nipple-areola complex
[54, 55]. The skin wound can be closed with a purse
string or horizontal suture, although this tends to reduce
the projection of the breast mound. A central excision4 International Journal of Breast Cancer
Figure 2: This patient presented with a 1cm tumour located in
the upper inner quadrant of the right breast. The tumour was
excisedviaaperiareolarincisionandtheremainingbreasttissuewas
mobilised to close the defect. The round block technique ensured
that the nipple-areolar complex remained in the correct position.
Table 2: Oncoplastic techniques suitable for excision of lesions in
speciﬁed locations.
Tumour location Oncoplastic technique
Superior to NAC Periareolar (Benelli) mammoplasty
Inferior pedicle (Grisotti)
mammoplasty
Lateral to NAC Lateral mammoplasty
Medial to NAC Medial mammoplasty
Lower outer/inner
quadrant
L-mammoplasty
J-mammoplasty
Inferior to NAC Vertical scar mammoplasty
Inverted T (WISE) mammoplasty
Inframammary fold IMF-plasty
with volume displacement using a Grisotti dermoglandular
ﬂap is more appropriate for larger breasts with greater
degrees of ptosis [56]. After excision of the nipple-areola
complex and the underlying tumour, a dermoglandular
ﬂap is harvested from the inferolateral breast. The ﬂap is
then de-epithelialised apart from the circle of skin destined
to reconstruct the nipple. Free rotation depends on the
ﬂap being freed from the prepectoral fascia. An inverted-
T (WISE pattern) mammoplasty [53], excising the nipple-
areola complex, is a popular alternative, with the nipple
potentially being reconstructed at a later date.
For central tumours not involving the nipple-areola
complex an alternate option would be the use of Benelli’s
round block technique (Figure 2)[ 57]. Concentric circles are
incised around the areola, and the skin resected, allowing
access to the periareolar tissue. This allows reshaping of
the breast by mobilising adjacent tissue, and the skin is
closed by means of a purse string suture [58]. Alternatively
such tumours may be excised in combination with a
batwing mastopexy, otherwise known as the omega plasty,
while preserving the nipple-areola complex [59]. Brieﬂy,
semicircular incisions are made: one circumareolar and the
other a short distance away, and these are joined by angled
“wings” to each side of the areola. After excision of the breast
lesion, the defect is closed by advancing the breast tissue and
closing the skin.
6. OptimisingCosmesis: PeripheralTumours
Occupying 10–20% of Breast Volume
Diﬀerent oncoplastic techniques lend themselves to excision
of lesions in certain locations (see Table 2). Tumours above
the nipple-areola complex may be excised and the defect
ﬁlled with an inferior pedicle mammoplasty.
Excision of tumours in the lateral aspect of the breast:
tumours inferior to the nipple-areola complex may be
excised by means of a vertical mammoplasty [60, 61]o r
nipple-sparing inverted-T mammoplasty [53] (Figures 3(a)
and 3(b)). Moderately sized tumours in the lower outer
quadrant may be resected using a modiﬁed approach, some-
times referred to as the J-mammoplasty, with larger tumours
excised via an inverted-T or L-mammoplasty.
Tumours close to the inframammary fold may be re-
moved by excising an ellipse of skin and breast tissue and
simply closing the resulting defect. Although this reduces the
distance from nipple to inframammary fold, this is often not
apparent in patients with preexisting ptosis.
7. OptimisingCosmesis afterExtensive
Excision of 20–40% of Breast Volume:
Techniques of Tissue Transfer
When more than 20% of breast volume is excised, tis-
sue mobilisation alone may not succeed in achieving a
satisfactory result and, unless the patient desires a much
smaller breast, volume replacement by tissue transfer may
be necessary. Most commonly, this entails use of a pedicled
latissimus dorsi miniﬂap (Figures 4(a) and 4(b)), which can
bemobilisedtoﬁlladefectinanyquadrant[62,63].Theﬁrst
stage of the procedure involves excision of the breast lesion,
andthenthelatissimusdorsiminiﬂapisusedtoﬁllthedefect
afteradelayofoneortwoweekstoallowthemarginstatusto
beassessed[64].Ifintraoperativeanalysisofsurgicalmargins
by frozen section is available, then a single stage procedure is
feasible [65, 66]. Alternatives include mobilisation of axillary
tissue on a thoracodorsal artery perforator lipodermal ﬂap
[7] or use of intercostal artery perforator ﬂaps [66]. One
novel approach adopted in our unit is to laparoscopically
h a r v e s ta no m e n t a lﬂ a p( F i g u r e s5(a) and 5(b)) to ﬁll the
local defect [67]. Whereas pedicled ﬂaps usually withstand
radiotherapy, albeit with a substantial rate of complications,
the use of free ﬂaps in this context is contraindicated.
8. OptimisingManagement of Multifocaland
MulticentricTumours
The management of multifocal tumours, within the same
quadrant, and multicentric tumours, in diﬀerent quadrantsInternational Journal of Breast Cancer 5
(a) (b)
Figure 3: (a) This 63-year-old patient with large ptotic breasts presented with a tumour in the right breast. The skin markings show the
planned incisions for a therapeutic inverted-T mammoplasty. (b) Postoperative images of the same patient after completion of adjuvant
chemotherapy and prior to commencing radiotherapy. The inverted-T mammoplasty gives a satisfactory result and is in proportion to the
patient’s body habitus. Reduction mammoplasty of the contralateral breast, to improve symmetry, is planned to be performed six months
after completion of adjuvant radiotherapy.
(a) (b)
Figure 4: (a) This 41-year-old patient had previously undergone wide local excision of a tumour in the left breast. The lateral margin
was involved, necessitating a further central wide local excision to include the nipple-areolar complex. (b) In view of the predicted loss of
volume, a latissimus dorsi miniﬂap was utilised to both ﬁll the resultant defect and also replace the skin of the areola. The volume of the
partially reconstructed breast is very similar to that of the contralateral side, although postoperative swelling is apparent.
(a) (b)
Figure 5: (a) This patient had previously undergone wide local excision and adjuvant radiotherapy for a cancer located in the lower inner
quadrant of the left breast. The resulting defect causes signiﬁcant distortion to the breast shape and nipple deviation toward the midline.
(b) An omental ﬂap was harvested laparoscopically in order to partially reconstruct the breast, achieving a high degree of symmetry with the
contralateral breast.6 International Journal of Breast Cancer
or in the same quadrant but widely separated (>5cm),
is controversial. Traditionally these scenarios would dictate
mastectomy as the only oncologically sound procedure. If a
conservative procedure is to be considered in these patients,
careful selection is required with regard to tumour location
and breast size and shape and counselled regarding the
increased likelihood of further surgery should margins be
positive, and possible increased risk of local recurrence,
which may entail completion mastectomy. There have been
no randomised controlled trials to address the issue of the
oncological safety of breast conservation surgery in this
context [7]. A retrospective study comparing outcomes of
patients with multifocal and unifocal cancers showed equiv-
alent overall survival and no increase in risk of locoregional
recurrence [68].
In general, tumours closely spaced within the breast may
be removed together utilising an appropriate technique such
as an omegaplasty or inverted-T mammoplasty as listed
above, whereas separate wide excisions are more appropriate
for tumours separated by >5cm. Careful preoperative plan-
ning is of paramount importance. This may often include
the use of magnetic resonance imaging, and image-guided
localisation of all lesions to be excised is essential. Access
to intraoperative frozen section histology, while desirable in
terms of reducing the need for further surgery in case of
margin involvement, is not an absolute prerequisite.
9. Optimising Management of
LocalRecurrenceorMetachronous
IpsilateralPrimaryBreast Cancer
Theroleoffurtherattemptsatbreastconservationinpatients
who have previously undergone wide local excision for an
ipsilateral cancer is controversial. Whole-breast radiother-
apy can only be given once, and therefore further breast
conservation surgery alone, versus mastectomy, is subject to
the same disparity in eﬃcacy as when wide local excision,
without radiotherapy, is compared with mastectomy for
primary breast cancer [28]. Thus, perhaps as many as 40%
of women treated in this way will have further problems
with local recurrence. Given these odds, many women will
opt for mastectomy rather than any further attempt at breast
conservation, but partial breast radiotherapy may be used
in this context in an attempt to reduce the risk of failure
[69]. At present, partial breast radiotherapy is only oﬀered
to a minority of patients. As these techniques gain wider
acceptance and enter routine practice, a greater proportion
of patients may be eligible for further breast conservation
surgery to manage local recurrence or metachronous ipsilat-
eral primary breast cancer.
10.OptimisingSymmetry:
When to Perform Contralateral Surgery
Large volume excisions, in patients for whom breast reduc-
tion is desirable, often result in noticeable asymmetry,
which should be corrected. There is no consensus regarding
the optimal timing of contralateral surgery. Simultaneous
procedures are attractive in terms of reducing patient incon-
venience and the need for a second admission and general
anaesthetic (Figures 6(a) and 6(b)). Conversely, postradio-
therapy changes can be unpredictable, and, therefore, some
prefer to perform the contralateral reduction after these have
had time to settle, to improve the chance of achieving good
symmetry. A delayed approach also takes into account the
possibility that further surgery may be required in the form
of excision of margins or completion mastectomy if excision
is incomplete [59]. If contralateral reduction is planned as a
simultaneous procedure, then slightly more tissue should be
excisedandthenippleplacedmarginallyhigher,tomimicthe
predicted postradiotherapy shape [55].
11.NovelTechnologies andtheFutureof
OptimisingBreast Conservation
Endoscopic breast surgery for benign and malignant disease
has been described in a number of small case series [70, 71].
Carbondioxideinsuﬄationcreatesaworkingspaceandboth
subcutaneous mastectomy and wide local excision have been
performed using this technique. Although usually employed
inthemanagementofductalcarcinomainsitu,excisionofT1
carcinomas has also been successfully performed [72]. The
ability to reliably excise tumours with clear surgical margins
is not well established due to the small size of these case
reports, and more work is needed before they will be readily
adopted into routine practice [73].
Radiofrequency ablation for small breast tumours is
currently under evaluation [74]. The procedure can be mon-
itored intraoperatively by ultrasound and postoperatively by
magnetic resonance imaging. Wide local excision may be
performed after radiofrequency ablation to ensure adequate
oncological treatment [75]. Concerns regarding the ability
to accurately assess response by magnetic resonance imaging
alonecurrentlyprecludetheuseofthistechniqueinisolation
[76]. Fine-needle aspiration cytology in conjunction with
magneticresonanceimaginghasbeenusedtoassessresponse
in patients not undergoing excision [77], but this approach
should not be employed outside of clinical research given
its unproven sensitivity and inability to adequately sample
the “margin” of ablation and because of the paucity of data
related to long-term outcomes.
12. Conclusion
The role of surgery in the management of breast cancer
has changed markedly since the days of Halsted, reﬂecting
the change in the way breast cancer is perceived as a
systemic, rather than locoregional, disease process. Mul-
timodal therapies, especially in the form of neoadjuvant
chemotherapy and endocrine therapy, have increased the
proportion of women eligible for breast conservation. The
adoption of relatively straightforward surgical techniques
to achieve volume displacement can give superior cosmetic
outcomes for patients with larger tumours. Techniques of
volume replacement are more demanding but are within theInternational Journal of Breast Cancer 7
(a) (b)
Figure 6:(a)This51-year-oldpatientwithlarge,ptoticbreastsandnipple-areolacomplexessituatedmedialtothebreastmeridianpresented
with a left breast cancer. These images show the skin markings used to plan a therapeutic inverted-T mammoplasty and simultaneous
contralateral reduction mammoplasty for symmetrisation. (b) Adjuvant radiotherapy to the left breast has resulted in mild changes in skin
pigmentation but symmetry is still good with the contralateral breast being still satisfactory.
remit of surgeons with an interest in oncoplastic surgery or
can be performed in conjunction with a plastic surgeon.
The management of multifocal or multicentric cancers
and the management of further conservation surgery for
recurrence or metachronous ipsilateral primary after pre-
vious wide local excision are contentious issues. Ideally,
multicentre randomised controlled trials should be designed
to address these issues. Surgery to the contralateral breast
t oi m p r o v es y m m e t r ys h o u l db eo ﬀered to all patients. The
timing of such surgery, and the merits of synchronous versus
delayedapproaches,shouldbediscussedwithpatientsinfull.
In the future, endoscopic breast cancer surgery and
radiofrequency ablation therapy are likely to become more
popular, but larger studies with longer periods of followup
are needed to evaluate their oncological safety prior to their
widespread adoption.
Now that patients are beneﬁting from improved disease-
free and overall survival, the cosmetic outcome is of great
importance as patients seek to come to terms with the
aftermathofbreastcanceranditstreatment.Theimportance
of cosmesis, in terms of emotional and psychosexual well-
being [78–80], demands that the principles of an oncoplastic
approach to breast conservation surgery be employed in
treating all women with breast cancer.
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